Genetic, Genomic Testing to Play Key Role in Quest Diagnostics' Growth Efforts | GenomeWeb

NEW YORK (GenomeWeb News) – Quest Diagnostics held its first-ever Investor Day last Friday in New York providing a highly detailed view of its refocused strategy aimed at gaining share in the diagnostic testing market and its plans to revive flagging revenues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.